Powder: -20°C for 3 years
In solvent: -80°C for 2 years
MRS 1754 is a selective antagonist radioligand for the A2B adenosine receptor. It has a very low affinity for A1 and A3 receptors of both humans and rats.
Description | MRS 1754 is a selective antagonist radioligand for the A2B adenosine receptor. It has a very low affinity for A1 and A3 receptors of both humans and rats. |
Targets&IC50 | A2B:1.45±0.21 nM(Ki, human) |
In vitro | The Ki value for displacement of [3H]MRS 1754 binding to human A2B receptors expressed in HEK-293 cell membranes is 1.45±0.21 nM. The most effective displacer of [3H]MRS 1754 binding is MRS 1754. . |
Molecular Weight | 486.52 |
Formula | C26H26N6O4 |
CAS No. | 264622-58-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 15 mg/mL (30.83 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MRS 1754 264622-58-4 GPCR/G Protein Neuroscience Adenosine Receptor MRS-1754 Inhibitor P1 receptor MRS1754 inhibit inhibitor